亚洲免费av电影一区二区三区,日韩爱爱视频,51精品视频一区二区三区,91视频爱爱,日韩欧美在线播放视频,中文字幕少妇AV,亚洲电影中文字幕,久久久久亚洲av成人网址,久久综合视频网站,国产在线不卡免费播放

        ?

        Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine

        2021-01-07 23:21:09JeraldSadoffetal
        四川生理科學(xué)雜志 2021年1期

        Jerald Sadoff, et al.

        Background: Efficacious vaccines are urgently needed to contain the ongoing coronavirus disease 2019 (Covid-19)pandemic of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).A candidate vaccine,Ad26.COV2.S, is a recombinant, replication-incompetent adenovirus serotype 26 (Ad26) vector encoding a full-length and stabilized SARS-CoV-2 spike protein.

        Methods: In this multicenter, placebo-controlled, phase 1-2a trial, we randomly assigned healthy adults between the ages of 18 and 55 years (cohort 1) and those 65 years of age or older (cohort 3) to receive the Ad26.COV2.S vaccine at a dose of 5×1010 viral particles (low dose) or 1×1011 viral particles (high dose) per milliliter or placebo in a single-dose or two-dose schedule.Longer-term data comparing a single-dose regimen with a two-dose regimen are being collected in cohort 2; those results are not reported here.The primary end points were the safety and reactogenicity of each dose schedule.

        Results: After the administration of the first vaccine dose in 805 participants in cohorts 1 and 3 and after the second dose in cohort 1, the most frequent solicited adverse events were fatigue, headache, myalgia, and injection-site pain.The most frequent systemic adverse event was fever.Systemic adverse events were less common in cohort 3 than in cohort 1 and in those who received the low vaccine dose than in those who received the high dose.Reactogenicity was lower after the second dose.Neutralizing-antibody titers against wild-type virus were detected in 90% or more of all participants on day 29 after the first vaccine dose (geometric mean titer [GMT], 224 to 354) and reached 100% by day 57 with a further increase in titers (GMT, 288 to 488), regardless of vaccine dose or age group.Titers remained stable until at least day 71.A second dose provided an increase in the titer by a factor of 2.6 to 2.9 (GMT, 827 to 1266).Spike-binding antibody responses were similar to neutralizing-antibody responses.On day 14, CD4+ T-cell responses were detected in 76 to 83% of the participants in cohort 1 and in 60 to 67% of those in cohort 3, with a clear skewing toward type 1 helper T cells.CD8+ T-cell responses were robust overall but lower in cohort 3.

        Conclusions: The safety and immunogenicity profiles of Ad26.COV2.S support further development of this vaccine candidate.(Funded by Johnson & Johnson and the Biomedical Advanced Research and Development Authority of the Department of Health and Human Services; COV1001 ClinicalTrials.gov number, NCT04436276.).

        午夜无码一区二区三区在线| 精品国际久久久久999波多野| 77777亚洲午夜久久多喷| 亚洲va中文字幕无码毛片| 中文字幕一区二区三区久久网站| 国产美女a做受大片免费| 亚洲高清国产拍精品熟女| 国产av一级片在线观看| 亚洲精品国产电影| 一个人看的视频www免费| 亚洲av美女在线播放啊| 在线无码免费看黄网站| 亚洲色图偷拍自拍在线| 少妇性bbb搡bbb爽爽爽| 国产主播一区二区三区在线观看| 久久人妻AV无码一区二区| 国产在线精彩自拍视频| 亚洲天堂av在线免费观看| 亚洲欧美国产精品久久| 熟妇与小伙子matur老熟妇e| 98精品国产综合久久| 国产大陆av一区二区三区| 国产黄久色一区2区三区| 99国产精品久久久久久久成人热| 纯爱无遮挡h肉动漫在线播放| 岛国AV一区二区三区在线观看| 人妻丝袜中文字幕久久| 日本一二三区在线不卡| 国产精品二区一区二区aⅴ污介绍| 成年女人vr免费视频| 亚洲熟女综合一区二区三区| 香蕉视频一级片| 无码91 亚洲| 高清不卡av在线播放| 国产黄大片在线观看画质优化| 激情偷乱人伦小说视频在线| 一本大道久久a久久综合| 按摩少妇高潮在线一区| 在线观看一级黄片天堂| 国产做a爱片久久毛片a片| 仙女白丝jk小脚夹得我好爽|